Human Platelets Take up Anti-VEGF Agents
Purpose. Growing evidence suggests different systemic exposure of anti-vascular endothelial growth factor (anti-VEGF) agents with repeated intravitreal application. Since the penetration of anti-VEGF agents through vascular barrier was reported, the interaction of anti-VEGF with nonresident platelet...
Saved in:
Main Authors: | B. Sobolewska, B. Fehrenbacher, P. Münzer, H. Kalbacher, S. Geue, Konstantinos Stellos, M. Schaller, F. Ziemssen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2021/8811672 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Anti-VEGF Agents in Glaucoma Surgery
by: Mark Slabaugh, et al.
Published: (2017-01-01) -
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
by: Kenichi Kimoto, et al.
Published: (2012-01-01) -
Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01) -
The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury
by: Xiao Zhao, et al.
Published: (2021-01-01) -
Anti-VEGF Treatment Strategies for Wet AMD
by: Jaclyn L. Kovach, et al.
Published: (2012-01-01)